Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 74.55% | -159.76% | -235.71% | -540.33% | -217.03% |
| Total Depreciation and Amortization | -4.65% | -14.09% | -21.47% | -25.60% | -19.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.22% | 157.15% | 208.14% | 157.54% | 119.81% |
| Change in Net Operating Assets | -354.80% | -184.34% | -91.11% | 171.25% | 41.70% |
| Cash from Operations | -22.01% | -75.76% | -34.20% | -26.27% | -89.35% |
| Capital Expenditure | -81.54% | -66.41% | -2.85% | -56.83% | -18.28% |
| Sale of Property, Plant, and Equipment | -59.61% | 5.88% | -22.17% | 40.10% | 88.11% |
| Cash Acquisitions | -- | 98.86% | 98.86% | 99.77% | 99.78% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -130.22% | 265.19% | 524.32% | 125.19% | 200.76% |
| Cash from Investing | -250.01% | 91.50% | 108.31% | 98.52% | 114.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 91.13% | 80.20% | 68.70% | -2,351.25% | -1,774.04% |
| Issuance of Common Stock | 1,600.00% | -100.00% | -100.00% | -80.00% | -90.32% |
| Repurchase of Common Stock | 88.76% | 19.08% | 55.64% | 62.30% | 63.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.86% | 40.75% | 58.29% | 35.98% | 38.05% |
| Foreign Exchange rate Adjustments | 63.09% | 139.09% | 30.00% | 43.45% | 67.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -334.84% | 69.42% | 108.41% | 95.99% | 121.04% |
